Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bacterial acid production on the tooth surface is not a single molecular entity, receptor, or defined protein, but rather a metabolic process involving multiple bacterial species and enzymes in dental plaque that ferment carbohydrates to acids, primarily lactic acid, leading to tooth demineralization[2][4][3][6][7]. Therefore, it is not considered a traditional therapeutic target such as a receptor or enzyme, and its naming does not correspond to a canonical molecule. Bacterial acid production on the tooth surface refers to the metabolic process by which plaque bacteria (such as **Streptococcus mutans**, lactobacilli, and others) ferment dietary carbohydrates—mainly sucrose, glucose, and fructose—into organic acids ( predominantly **lactic acid**) within dental biofilm attached to the enamel surface[2][3][4][8][6]. This acid lowers local pH, causing demineralization (dissolving) of hydroxyapatite crystals in enamel when pH drops below the critical threshold (approx. 5.5 for enamel), which can culminate in dental caries if remineralization does not dominate[1][2][7]. The microbial composition, dietary carbohydrate intake, plaque density, and properties of saliva (buffering capacity) all modulate the rate and severity of acid production and resulting dental disease[1][2][3][7][8]. Direct interventions target the **bacterial community or their substrate**, not the acid itself. Strategies for caries control include antimicrobial treatments, mechanical plaque removal, dietary modification (reducing fermentable carbohydrate intake), use of fluoride (to foster formation of less-soluble fluorapatite in enamel), and, in some cases, pH-modifying agents[1][2]. There are no drugs that selectively bind to or inhibit "bacterial acid production" as a discrete biochemical target. **Summary:** "Bacterial acid production on tooth surface" is a **metabolic function of oral biofilm microbiota**, not a canonical molecular or pharmacological target. Interventions modify microbial ecology or substrate availability and are not directed at a singular receptor or molecule[2][1][3][4][7][8].
not applicable (see below for interventions)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial acid production on the tooth surface.